[1] Anais P, Emilie G, Sophie C, et al. Liver transplantation for hepatocellular carcinoma after down staging with sorafenib: a monocentric case-matched series. J Gastrointestin Liver Dis, 2020,29(1):120-121.
[2] 张锋, 殷小平, 边静, 等. Gd-EOB-DTPA增强MRI肝胆特异期图像纹理分析在肝细胞癌病理分化中的应用研究. 临床放射学杂志,2020,39(5):922-926.
[3] Araki K, Harimoto N, Yamanaka T, et al. Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus. Surg Today, 2020,50(11):1496-1506.
[4] Rimola J, Forner A, Sapena V, et al. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. Eur Radiol, 2020, 30(1):186-194.
[5] Ryu T, Takami Y, Wada Y, et al. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. J Gastrointest Surg, 2019, 23(4):779-787.
[6] 许露露, 舒健, 杨春梅. MRI影像组学评估肝细胞肝癌的病理分级. 临床放射学杂志,2020,39(8):1520-1523.
[7] Rich NE, Hester C, Odewole M, et al. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma. Clin Gastroenterol Hepatol, 2019, 17(3):551-559.
[8] Chetana L, Michael O, Eylon L, et al. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study. Surg Endosc, 2019, 33(3):811-820.
[9] 钟熹, 李建生, 陈志军, 等. MR扩散加权成像纹理分析鉴别肝硬化背景下不典型强化的小肝癌和增生结节. 中华肝脏病杂志,2020,28(1):37-42.
[10] 李勇, 宋琦炜. 肝硬化背景下超声造影鉴别诊断肝细胞肝癌和血管瘤的价值分析. 肝脏, 2017, 11(22):62-65.
[11] 范宪淼, 郑晓林, 邹玉坚, 等. 动态增强MRI药代动力学参数与肝细胞癌组织分化程度、微血管密度的关系. 山东医药,2019,59(25):68-70
[12] 成东亮, 黄伟康, 文戈, 等. MRI在评估肝细胞癌分化程度中的研究进展. 磁共振成像, 2019, 10(9):703-706.
[13] 胡梦洁, 郁义星, 范艳芬, 等. 钆塞酸二钠增强磁共振影像学特征联合定量分析在预测肝细胞癌病理分级中的价值. 中华医学杂志, 2020, 100(17):1299-1304.
[14] 张涛, 陆健, 张学琴, 等. 钆塞酸二钠增强T1-mapping成像和DWI对肝纤维化分期的评估价值. 放射学实践,2020,35(2):203-207.
[15] 陈佳, 文利, 龚明福, 等. Gd-EOB-DTPA增强MRI评价肝细胞肝癌分化程度. 放射学实践,2018,33(12):1277-1281. |
